Health News Archive - June 13, 2010
SINGAPORE, June 13 /PRNewswire/ -- S*BIO Pte Ltd today announced the presentation of positive safety, tolerability and pharmacokinetic/pharmacodynamic (PK/PD) results for its novel oral JAK2 inhibitor, SB1518, at the 15th Congress of the European Hematology Association (EHA), June 10-13, in Barcelona, Spain. Data was presented on the Phase 1 clinical results of the Phase 1/2 dose-escalation trial of SB1518 from 20 patients treated at multiple dose levels ranging between 100 mg to 600 mg once daily.
Federal regulators are considering banning the serving of peanuts on commercial airline flights.
PRINCETON, N.J., June 13 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it will present at Goldman Sachs Annual Global Healthcare Conference on Tuesday, June 15, 2010 at 11:35 a.m. ET (8:35 a.m. PT).
The Food and Drug Administration is cracking down on 23andMe, as well as other companies that sell genetic tests directly to consumers.
Engineers turn a drawback â€” the stickiness of gold nanoparticles â€” into an advantage.
White blood cells with receptors for both virus and nerve proteins may assault nerves after fighting an infection.
Study into telomere length may improve understanding of the development of disease.
PHOENIX, June 13 /PRNewswire/ -- Jan Jester, RN, WOCN, CHPN, of Kansas City, KS, was honored today with this year's WOC Nurse Great ComebacksÂ® Award at the opening ceremony of the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses (WOCN) Society and the World Council of Enterostomal Therapists (WCET).
PHOENIX, June 13 /PRNewswire/ -- A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society (WOCN) and World Council of Enterostomal Therapists (WCET).
RIDGEFIELD, Conn., June 13 /PRNewswire/ -- Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients.